Precision Business Insights
Portfolio

 

Smart Pills Market

: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

Smart Pills Market: By Application (Drug Delivery, Capsule Endoscopy, Patient Monitoring), By Target Area (Stomach, Esophagus, Large Intestine, Small Intestine), By End User (Hospitals, Clinics, Research Institutes), and Geography 

 

 

Smart Pills Market Size:

 

Smart Pills Market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 

Market Outline:

Smart pills are the injectable medical devices taken orally to examine gastrointestinal tract. The advanced smart pills enable disease diagnosis, patient monitoring, and help to improve the drug delivery. Cameras, trackers, and sensors are commonly used smart pills swallowed by patient to get complete GI evaluation without surgery. Smart pills expected to replace the conventional diagnostic techniques such as colonoscopy and endoscopy.

 

Market Dynamics:

Increase in geriatric population coupled with rise in preference for minimally invasive surgical procedures are anticipated to drive the global smart pills market. Moreover, technological advancements of the smart pills, rise in prevalence of GI disorders, sophisticated healthcare infrastructure, wide applications with smart pills, and rise in disposable income are anticipated to fuel the global smart pills market over the forecast period. However, high cost of products, technological constraints the efficiency of capsule endoscopes, and patients fear regarding the smart pill swallowing are expected to dampen the growth of smart pills market.

 

Market Scope:

Smart Pills market is segmented based on the application, target area, and end user

 

Based on the application:

  • Drug Delivery
  • Capsule Endoscopy
  • Patient Monitoring

 

Based on the target area

  • Stomach
  • Esophagus
  • Large Intestine
  • Small Intestine

 

Based on the distribution channel

  • Hospitals
  • Clinics
  • Research Institutes

 

Regional Analysis:

Geographically, global smart pills market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America smart pills market has a lucrative share attributed to increase in the prevalence of GI disorders due to change in lifestyle, innovation of newer smart pills by market players, and favorable reimbursement policies are fuel the market. Europe smart pills market is poised to grow at a notable CAGR due to adoption of technologically advanced smart pills, rise in government investment in healthcare sector, and well established healthcare infrastructure. Asia Pacific smart pills market has a lucrative growth owing to large patient pool with GI disorders, increase in healthcare expenditure, and entry of market players into Asia Pacific region are fuel the market.

 

Competition Assessment:

Some of the players in the report include:

  • Medimetrics S.A. de C.V. (Mexico)
  • CapsoVision, Inc. (U.S.)
  • Bio-Images Research Limited (U.K.)
  • Olympus Corporation (Japan)
  • Given Imaging, Inc. (Israel)
  • SmartPill Corporation (U.S.)
  • Siemens Healthineers (U.S.)
  • Medtronic plc (Ireland)
  • Koninklijke Philips N.V. (Netherlands)
  • GE Healthcare (U.S.)
  • Otsuka America Pharmaceutical, Inc. (U.S.)

 

Notable Market Developments:

  • In November 2017, Otsuka America Pharmaceutical, Inc. received FDA approval for Abilify MyCite, (Aripiprazole tablets with sensor)

 

Key Features of the Report:

  • The report covers exhaustive regional information, that includes North America (The USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentina, Venezuela, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenari0
  • Medimetrics S.A. de C.V. (Mexico)
  • CapsoVision, Inc. (U.S.)
  • Bio-Images Research Limited (U.K.)
  • Olympus Corporation (Japan)
  • Given Imaging, Inc. (Israel)
  • SmartPill Corporation (U.S.)
  • Siemens Healthineers (U.S.)
  • Medtronic plc (Ireland)
  • Koninklijke Philips N.V. (Netherlands)
  • GE Healthcare (U.S.)
  • Otsuka America Pharmaceutical, Inc. (U.S.)

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials